# Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay

> **NCT02278913** · PHASE4 · COMPLETED · sponsor: **Universidad Nacional de Asunción** · enrollment: 134 (actual)

## Conditions studied

- Hyperglycemia
- Diabetes

## Interventions

- **DRUG:** Basal Bolus (Glargine and Glulisine)
- **DRUG:** Human Insulin

## Key facts

- **NCT ID:** NCT02278913
- **Lead sponsor:** Universidad Nacional de Asunción
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-04
- **Primary completion:** 2010-04
- **Final completion:** 2011-03
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2014-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02278913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02278913, "Basal Bolus Versus Human Insulin in Hospitalized Patients With Diabetes in Paraguay". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02278913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*